Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niccolò Bolli

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Cancers|February 25, 2022
The Dynamics of Nucleotide Variants in the Progression from Low-Intermediate Myeloma Precursor Conditions to Multiple Myeloma: Studying Serial Samples with a Targeted Sequencing ApproachBénedith Oben, Charlotte Cosemans, Ellen Geerdens, et al.
Cancers|October 13, 2021
Transcriptomic Analysis in Multiple Myeloma and Primary Plasma Cell Leukemia with t(11;14) Reveals Different Expression Patterns with Biological Implications in Venetoclax SensitivityKatia Todoerti, Elisa Taiana, Noemi Puccio, et al.
Cancers|May 28, 2020
Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering MyelomaMartina Manzoni, Valentina Marchica, Paola Storti, et al.
Journal of Cellular and Molecular Medicine|April 3, 2026
Identification of ceRNA Regulatory Networks Driven by the lncRNA NEAT1 in Multiple MyelomaDomenica Ronchetti, Valentina Traini, Ilaria Silvestris, et al.
Cancer Research|July 10, 2007
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutantsNiccolò Bolli, Ildo Nicoletti, M Felicetta De Marco, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 28, 2026
Undetectable Minimal Residual Disease in Multiple Myeloma: Bridging the Gap Between Clinical Trials and Real-life ApplicationRoberto Mina, Elisabetta Antonioli, Gregorio Barilà, et al.
Clinical and Experimental Medicine|March 5, 2024
Whole-exome sequencing is feasible on a fresh-frozen skin sample of intravascular large B cell lymphomaFilippo Bagnoli, Giuditta Pini, Bachisio Ziccheddu, et al.
Blood|February 26, 2013
The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse modelPaolo Sportoletti, Emanuela Varasano, Roberta Rossi, et al.
Frontiers in Immunology|June 4, 2021
CD40 Activity on Mesenchymal Cells Negatively Regulates OX40L to Maintain Bone Marrow Immune Homeostasis Under Stress ConditionsBarbara Bassani, Claudio Tripodo, Paola Portararo, et al.
Haematologica|September 8, 2022
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteinsElisa Taiana, Cecilia Bandini, Vanessa Katia Favasuli, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Cancers|February 25, 2022
The Dynamics of Nucleotide Variants in the Progression from Low-Intermediate Myeloma Precursor Conditions to Multiple Myeloma: Studying Serial Samples with a Targeted Sequencing ApproachBénedith Oben, Charlotte Cosemans, Ellen Geerdens, et al.
Cancers|October 13, 2021
Transcriptomic Analysis in Multiple Myeloma and Primary Plasma Cell Leukemia with t(11;14) Reveals Different Expression Patterns with Biological Implications in Venetoclax SensitivityKatia Todoerti, Elisa Taiana, Noemi Puccio, et al.
Cancers|May 28, 2020
Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering MyelomaMartina Manzoni, Valentina Marchica, Paola Storti, et al.
Journal of Cellular and Molecular Medicine|April 3, 2026
Identification of ceRNA Regulatory Networks Driven by the lncRNA NEAT1 in Multiple MyelomaDomenica Ronchetti, Valentina Traini, Ilaria Silvestris, et al.
Cancer Research|July 10, 2007
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutantsNiccolò Bolli, Ildo Nicoletti, M Felicetta De Marco, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 28, 2026
Undetectable Minimal Residual Disease in Multiple Myeloma: Bridging the Gap Between Clinical Trials and Real-life ApplicationRoberto Mina, Elisabetta Antonioli, Gregorio Barilà, et al.
Clinical and Experimental Medicine|March 5, 2024
Whole-exome sequencing is feasible on a fresh-frozen skin sample of intravascular large B cell lymphomaFilippo Bagnoli, Giuditta Pini, Bachisio Ziccheddu, et al.
Blood|February 26, 2013
The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse modelPaolo Sportoletti, Emanuela Varasano, Roberta Rossi, et al.
Frontiers in Immunology|June 4, 2021
CD40 Activity on Mesenchymal Cells Negatively Regulates OX40L to Maintain Bone Marrow Immune Homeostasis Under Stress ConditionsBarbara Bassani, Claudio Tripodo, Paola Portararo, et al.
Haematologica|September 8, 2022
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteinsElisa Taiana, Cecilia Bandini, Vanessa Katia Favasuli, et al.
Pageof 9